Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2025International Journal of Current Research and ReviewOpen Access

A Systematic Review of the Comparative Efficacy and Safety of Atomoxetine and Methylphenidate in the Treatment of Adults with ADHD

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMaria SitkoDSDominika StolarczykABAleksandra Bąk

Discussion

Loading...

Member takes

Overview

Systematic review compares efficacy and safety of atomoxetine and methylphenidate for ADHD treatment in adults, suggesting treatment options.

Key Points

  • Atomoxetine reduces hyperkinetic symptoms more effectively in adults with ADHD than methylphenidate.
  • Clinical trials show both medications are well tolerated and safe for adult patients.
  • The systematic review included 31 trials on atomoxetine and methylphenidate for ADHD treatment.
  • Efficacy in symptom reduction was significant for both atomoxetine and methylphenidate in adults with ADHD.

Cite This Study

Sitko et al. (2025) studied this question.

synapsesocial.com/papers/68af55ccad7bf08b1eadbef3https://doi.org/10.31782/ijcrr.2025.171301
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression2018 · 103 citations
  2. 2PHARMACOLOGICAL TREATMENT STRATEGIES FOR ADHD: A SYSTEMATIC REVIEW2025
  3. 3New Tool Summarizes the Evidence for ADHD Treatment Options2026
  4. 4Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)2025 · 6 citations
  5. 5Atomoxetine Versus Placebo for Cognitive Deficits in Stimulant Use Disorder: A Systematic Review2026 · 1 citations